Tag: metformin

Metformin mediates cardioprotection against aging‐induced ischemic necroptosis – Li – – Aging Cell – Wiley Online Library

Metformin mediates cardioprotection against aging‐induced ischemic necroptosis – Li – – Aging Cell – Wiley Online Library

“Notably, metformin treatment disrupted p62‐RIP1‐RIP3 complexes and effectively repressed I/R‐induced necroptosis in aged hearts, ultimately reducing mortality in this model. These findings highlight previously unknown mechanisms of aging‐related myocardial ischemic vulnerability: p62‐necrosome‐dependent necroptosis. Metformin acts as a cardioprotective agent that inhibits this unfavorable chain mechanism of aging‐related I/R susceptibility.”

https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13096?utm_campaign=RESR_MRKT_Researcher_inbound&af=R&utm_medium=referral&utm_source=researcher_app

The influence of metformin on IGF-1 levels in humans: A systematic review and meta-analysis

The influence of metformin on IGF-1 levels in humans: A systematic review and meta-analysis

We found in children, intervention duration <12 weeks yielded significant reductions in IGF-1, whilst paradoxically, in participants >18 years old, metformin intake significantly increased IGF-1. We suggest that caution be taken when interpreting the findings of this review, particularly given the discordant supplementation practices between children and adults.

https://www.sciencedirect.com/science/article/abs/pii/S104366181932081X?dgcid=rss_sd_all&utm_campaign=RESR_MRKT_Researcher_inbound&utm_medium=referral&utm_source=researcher_app

Growth Hormone DHEA Metformin In Aging Clinical Study

Growth Hormone DHEA Metformin In Aging Clinical Study

“A new clinical trial found that a combination of Growth Hormone, DHEA & Metformin helped to restore the size of the thymus gland and reverse biological age (epigenetic age via the GrimAge test).”

➢ Link to study:

Fahy, G. M., Brooke, R. T., Watson, J. P., Good, Z., Vasanawala, S. S., Maecker, H., et al. (2019). Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell, 18(6), 421–12. http://doi.org/10.1111/acel.13028

https://highintensityhealth.com/growth-hormone-dhea-metformin-in-aging-clinical-study/

Metformin

Metformin

Risks: this risk is low (less than 10 cases for 100,000 patient years), but the risk of metformin-induced lactic acidosis (MALA) increases in certain situations where both the plasma levels of metformin are increased and lactate clearance is impaired.[6]